Breathe Well Live Well
|
Glenmark, Aurobindo get US nod for asthma treatment drug
Moneycontrol.com … has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma. |
View full post on asthma – Google News
 Business Today |
Aurobindo gets USFDA nod for asthma drug
Moneycontrol.com Mon, Aug 06, 2012 at 16:09. Aurobindo gets USFDA nod for asthma drug. Aurobindo Pharma today said it has received the final approval from USFDA to manufacture and market montelukast sodium tablets used for treating asthma and allergies. Source: PTI … Glenmark hits 52-week high on US nod for asthma generic drug Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug Aurobindo gets US FDA nod for anti-asthma, chewable tablets |
View full post on asthma – Google News
 Zee News |
Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug
Economic Times NEW DELHI: Drug firms Aurobindo Pharma and Glenmark today said they have received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies. Both the companies said … Pharma cos set to gain from US nod for asthma drug |
View full post on asthma – Google News
|
Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA …
Economic Times NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug … |
View full post on asthma – Google News